Rationale and design of a study to evaluate the effects of sitagliptin on atherosclerosis in patients with diabetes mellitus: PROLOGUE study.
Department of Cardiovascular Medicine, Saga University Faculty of Medicine, Saga, Japan. Electronic address: junoyama@cc.saga-u.ac.jp.
Jun-Ichi
J
Oyama
Faculty of Medicine, Division of Clinical Medicine, Tsukuba University, Tsukuba, Japan.
Tomoko
T
Ishizu
Clinical Research Center, Chiba University Hospital, Chiba, Japan.
Yasunori
Y
Sato
Department of Cardiovascular Medicine, Saga University Faculty of Medicine, Saga, Japan.
Kazuhisa
K
Kodama
Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yasuko K
YK
Bando
Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Toyoaki
T
Murohara
Department of Cardiovascular Medicine, Saga University Faculty of Medicine, Saga, Japan.
Koichi
K
Node
D000328:Adult; D050197:Atherosclerosis / Q000188:drug therapy* / Q000209:etiology*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use*; D006801:Humans; D011446:Prospective Studies; D011719:Pyrazines / Q000627:therapeutic use*; D012107:Research Design; D000068900:Sitagliptin Phosphate; D014230:Triazoles / Q000627:therapeutic use*
D054873:Dipeptidyl-Peptidase IV Inhibitors; D011719:Pyrazines; D014230:Triazoles; D000068900:Sitagliptin Phosphate
Atherosclerosis; Carotid artery intima-media thickness; Sitagliptin